首页 | 本学科首页   官方微博 | 高级检索  
     

双介入法治疗肝癌的临床研究
引用本文:张祥林,王刚. 双介入法治疗肝癌的临床研究[J]. 辽宁医学院学报, 2010, 0(4): 293-294,305
作者姓名:张祥林  王刚
作者单位:辽宁医学院附属第一医院放射线科;
摘    要:目的研究与探讨肝动脉及门静脉双介入化疗栓塞对治疗原发性中晚期肝癌的临床疗效。方法76例中晚期肝癌患者分为A、B两组,A组应用肝动脉与门静脉双介入灌注化疗及栓塞(TACE+SPVE)方法治疗患者35例,B组单纯采用肝动脉灌注化疗及栓塞(TranscatheterArterialChemocmbolization,TACE)方法治疗患者41例。结果A、B两组的有效率分别为85.7%和63.4%,治疗后6个月、12个月、18个月的生存率,A组为91.4%、82.8%、68.6%,B组为82.9%、61.0%、43.9%,两组12个月和18个月间差异有显著性意义(P〈0.05)。结论应用肝动脉与门静脉双介入治疗中晚期肝癌,优于单纯肝动脉介入治疗的效果。

关 键 词:肝癌  肝动脉  门静脉  双介入治疗

The Clinical Study on Double Interventional Therapy for the Hepatic Carcinoma
ZHANG Xianglin,WANG Gang. The Clinical Study on Double Interventional Therapy for the Hepatic Carcinoma[J]. Journal of Liaoning Medical University (LNMU) Bimonthly, 2010, 0(4): 293-294,305
Authors:ZHANG Xianglin  WANG Gang
Affiliation:ZHANG Xianglin,WANG Gang(Department of Radiology,the First Affiliated Hospital of Liaoning Medical University,Jinzhou 121001 China)
Abstract:Objective To investigate the clinical effectiveness of chemotherapy and embolization with double interventional therapy through hepatic artery and portal vein in middle or advanced stage of hepatic carcinoma.Methods 76 patients of middle or advanced stage of hepatic carcinoma were divided into two groups at random.There were 35 patients with chemotherapy and embolization of double interventional therapy through hepatic artery and portal vein in Group A and 41 patients with chemotherapy and embolization of i...
Keywords:hepatic carcinoma  hepatic artery  portal vein  double interventional therapy  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号